Fate Therapeutics, Inc

(NASDAQ:FATE)

Latest On Fate Therapeutics, Inc (FATE):

Date/Time Type Description Signal Details
2023-05-24 02:16 ESTNewsFate Therapeutics: The Future Remains CloudyN/A
2023-05-03 23:29 ESTNewsFate Therapeutics GAAP EPS of -$0.19 beats by $0.47, revenue of $58.98M beats by $25.45MN/A
2023-05-03 23:28 ESTNewsFate Therapeutics, Inc. (FATE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 22:13 ESTNewsFate Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-24 09:55 ESTNewsFate Therapeutics: If You Are Comparing With Geron, Do It ThoroughlyN/A
2023-03-01 10:39 ESTNewsFate Therapeutics, Inc. (FATE) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 19:51 ESTNewsFate Therapeutics GAAP EPS of -$0.58 beats by $0.29, revenue of $44.34M beats by $25.93MN/A
2023-02-28 04:23 ESTNewsFate Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-07 01:07 ESTNewsFate faces slew of analyst downgrades after J&J's Janssen unit ends agreementN/A
2023-01-05 22:49 ESTNewsFate Therapeutics shares crater ~50% on ending tie-up with Janssen, layoffsN/A
2023-01-05 08:48 ESTNewsFate Therapeutics: iPSC Pioneer A Buy For Long-Term InvestorsN/A
2022-12-22 14:42 ESTNewsFate Therapeutics falls 6% after Oppenheimer downgrades rating to PerformN/A
2022-12-16 03:17 ESTNewsFate Therapeutics extends losses as Goldman initiates at SellN/A
2022-12-12 13:06 ESTNewsFate Therapeutics hits 52-week low after preclinical data on leukemia treatmentN/A
2022-11-16 11:24 ESTNewsFate Therapeutics: Promising Potential, Agonizingly Slow ProgressN/A
2022-11-15 01:50 ESTNewsFate Therapeutics: Returning To The Ticker That Changed The Way I InvestN/A
2022-11-04 02:21 ESTNewsFate Therapeutics GAAP EPS of -$0.86 beats by $0.04, revenue of $14.98M misses by $0.51MN/A
2022-11-04 02:20 ESTNewsFate Therapeutics, Inc. (FATE) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 08:43 ESTNewsFate Therapeutics Q3 2022 Earnings PreviewN/A
2022-08-30 20:33 ESTNewsFate Therapeutics: Yes For Speculators, No For Defensive InvestorsN/A
2022-08-18 13:32 ESTNewsFate Therapeutics gains as Wells Fargo cites upcoming catalystsN/A
2022-08-05 02:30 ESTNewsFate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 20:24 ESTNewsFate Therapeutics GAAP EPS of -$0.79 beats by $0.04, revenue of $18.55M beats by $5.99MN/A
2022-08-03 05:44 ESTNewsFate Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-28 23:27 ESTNewsNeedham initiates Fate Therapeutics coverage on potential of stem cell therapiesN/A
2022-07-01 04:26 ESTNewsFate Therapeutics names Brian Powl as chief commercial officerN/A
2022-06-28 22:46 ESTNewsFate, Ono expand team up on cancer immunotherapy programN/A
2022-06-04 00:17 ESTNewsFate: Possible Speedy FDA Approval Process With RMAT DesignationN/A
2022-05-05 03:04 ESTNewsFate Therapeutics GAAP EPS of -$0.68 beats by $0.11, revenue of $18.4M beats by $9.39MN/A
2022-05-05 03:03 ESTNewsFate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 06:19 ESTNewsFate Therapeutics Q1 2022 Earnings PreviewN/A
2022-03-01 06:16 ESTNewsFate Therapeutics GAAP EPS of -$0.72 misses by $0.04, revenue of $17.07M beats by $5.52MN/A
2022-03-01 06:15 ESTNewsFate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 10:17 ESTNewsFate Therapeutics Q4 2021 Earnings PreviewN/A
2022-02-21 08:17 ESTNewsFate Therapeutics: Slowly Getting To An Attractive PositionN/A
2022-02-11 21:06 ESTNewsFate Therapeutics (FATE) Investor Presentation - SlideshowN/A
2022-02-01 08:32 ESTNewsOne of the largest biotech ETFs has the second highest short interest float of U.S. ETFsN/A
2021-12-28 07:04 ESTNewsCentury, Fate drop after FDA’s Fast Track status for Celularity’s NK cell candidateN/A
2021-12-16 06:26 ESTNewsFate Therapeutics upgraded at Wedbush after data for off-the-shelf candidatesN/A
2021-12-13 19:18 ESTNewsFate up 5% after hours on interim phase 1 data on B-cell lymphoma candidateN/A
2021-12-08 06:01 ESTNewsFate Therapuetics rises 13% on outperform initiation from CowenN/A
2021-12-06 15:08 ESTNewsFate Therapeutics: Data Playing Catchup With ValuationN/A
2021-11-10 07:30 ESTNewsFate Therapeutics upgraded at Citi on valuation ahead of key catalystsN/A
2021-11-05 05:31 ESTNewsFate Therapeutics EPS beats by $0.13, beats on revenueN/A
2021-11-05 05:29 ESTNewsFate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 08:32 ESTNewsFate Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-13 00:32 ESTNewsWarning: FATE is at high risk of performing badlyN/A
2021-10-07 09:57 ESTNewsFATE is at high risk of performing badlyN/A
2021-09-29 14:49 ESTNewsWarning: FATE has been downgraded to Very BearishN/A
2021-09-21 17:49 ESTNewsFate Therapeutics posts encouraging data from FT538 preclinical studyN/A

About Fate Therapeutics, Inc (FATE):

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors, as well as ProTmune for the treatment of hematologic malignancies and rare genetic disorders. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

See Advanced Chart

General

  • Name Fate Therapeutics, Inc
  • Symbol FATE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 279
  • Fiscal Year EndDecember
  • IPO Date2013-10-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.fatetherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 231.92
  • Price/Book (Most Recent Quarter) 21.59
  • Enterprise Value Revenue 251.74
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.86
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.41
  • Operating Margin -407%
  • Return on Assets -17%
  • Return on Equity -55%
  • Revenue 31.43 million
  • Earnings Per Share -$1.22
  • Revenue Per Share $0.38
  • Gross Profit -94189000
  • Quarterly Earnings Growth 467.3%
View More

Highlights

  • Market Capitalization 8.06 billion
  • EBITDA -76343000
  • PE Ratio -2.04
  • Analyst Target Price $113.65
  • Book Value Per Share $4.38
View More

Share Statistics

  • Shares Outstanding 93.78 million
  • Shares Float 79.71 million
  • % Held by Insiders 179%
  • % Held by Institutions 100.89%
  • Shares Short 10.3 million
  • Shares Short Prior Month 9.63 million
  • Short Ratio 11
  • Short % of Float 15%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta 1.65
  • 52 Week High $121.16
  • 52 Week Low $19.81
  • 50 Day Moving Average 95.77
  • 200 Day Moving Average 71.47
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Fate Therapeutics, Inc (FATE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Fate Therapeutics, Inc (FATE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$15.9 million-$0.61-$0.38-61.55%
2020-09-302020-11-05$7.56 million-$0.68-$0.36-88.84%
2020-06-302020-08-05$5.47 million-$0.35-$0.29-19.49%
2020-03-312020-05-11$2.52 million-$0.44-$0.39-12.88%
2019-12-312020-03-02$2.8 million-$0.37-$0.371.25%
2019-09-302019-11-05$2.43 million-$0.40-$0.36-10.13%
2019-06-302019-08-06$2.82 million-$0.36-$0.31-16.92%
2019-03-312019-05-07$2.63 million-$0.30-$0.23-32.04%
2018-12-312019-03-05$1.66 million-$0.25-$0.24-3.01%
2018-09-302018-11-01$1.03 million-$0.31-$0.28-12.36%
2018-06-302018-08-06$1.03 million-$0.37-$0.32-16.5%
2018-03-312018-05-10$1.03 million-$0.27-$0.22-22.73%
2017-12-312018-03-05$1.03 million-$0.29-$0.25-16%
2017-09-302017-11-01$1.03 million-$0.26-$0.25-3.03%
2017-06-302017-08-14$1.03 million-$0.23-$0.230.86%
2017-03-312017-05-15$1.03 million-$0.24-$0.20-22.45%
2016-12-312017-03-16$1.03 million-$0.21-$0.2826.06%
2016-09-302016-11-07$1.03 million-$0.27-$0.284.15%
2016-06-302016-08-08$1.03 million-$0.29-$0.315.84%
2016-03-312016-05-09$1.32 million-$0.29-$0.27-8.74%
2015-12-312016-03-03$1.08 million-$0.26-$0.271.89%
2015-09-302015-11-03$1.03 million-$0.24-$0.3020%
2015-06-302015-08-05$329000-$0.33-$0.3915.38%
2015-03-312015-05-07$N/A-$0.38-$0.36-5.56%
2014-12-312015-03-12$N/A-$0.30-$0.313.23%
2014-09-302014-11-11$N/A-$0.32-$0.333.03%
2014-06-302014-08-12$N/A-$0.30-$0.3718.92%
2014-03-312014-05-13$N/A-$0.34-$0.33-3.03%
2013-12-312014-03-17$762000-$0.29-$0.27-7.41%
2013-09-302013-11-13$209000-$4.81-$0.32-1403.13%

Fate Therapeutics, Inc (FATE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Fate Therapeutics, Inc (FATE) Chart:

Fate Therapeutics, Inc (FATE) News:

Below you will find a list of latest news for Fate Therapeutics, Inc (FATE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Fate Therapeutics, Inc (FATE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-06-212.51.8CALL0 10TRUE00
2024-06-2150.1CALL0 1110FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-21100CALL0 00FALSE00
2024-06-212.50.05PUT50 1367.93FALSE0.050
2024-06-2151.4PUT0 21942.2TRUE00
2024-06-217.50PUT0 00TRUE00
2024-06-21100PUT0 01491.04TRUE00
2024-07-192.50CALL0 00TRUE00
2024-07-1950.2CALL0 1150FALSE00
2024-07-197.50.08CALL0 700FALSE00
2024-07-192.50PUT0 00FALSE00
2024-07-1950PUT0 0428.72TRUE00
2024-07-197.50PUT0 0454.08TRUE00
2024-08-162.51.9CALL0 340TRUE00
2024-08-1650.15CALL0 215116.78FALSE00
2024-08-167.50.43CALL0 1500FALSE00
2024-08-16100.05CALL0 2410FALSE00
2024-08-1612.50.12CALL0 550FALSE00
2024-08-16150CALL0 00FALSE00
2024-08-162.50.13PUT0 40FALSE00
2024-08-1651.23PUT0 161161.02TRUE00
2024-08-167.54PUT0 10194.31TRUE00
2024-08-16100PUT0 0297.33TRUE00
2024-08-1612.50PUT0 0403.21TRUE00
2024-08-16150PUT0 0298.21TRUE00
2024-11-152.51.4CALL0 12138.78TRUE00
2024-11-1550.61CALL0 53282.22FALSE00
2024-11-157.50.4CALL0 120FALSE00
2024-11-15100.15CALL0 250FALSE00
2024-11-1512.50.65CALL0 1000FALSE00
2024-11-15150.1CALL0 490FALSE00
2024-11-152.50.3PUT0 19108.65FALSE00
2024-11-1551.63PUT0 54105.19TRUE00
2024-11-157.50PUT0 0219.17TRUE00
2024-11-15100PUT0 0176.24TRUE00
2024-11-1512.50PUT0 0215.65TRUE00
2024-11-15150PUT0 0192.32TRUE00

Latest FATE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST63$17.82
Jun 13, 2022 7:59 PM EST1$17.815
Jun 13, 2022 7:59 PM EST27$17.81
Jun 13, 2022 7:59 PM EST100$17.81
Jun 13, 2022 7:59 PM EST100$17.81

Fate Therapeutics, Inc (FATE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1434316/000110465920074302/0001104659-20-074302-index.htm
2019-01-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434316/000003877719000001/0000038777-19-000001-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434316/000021545719006846/0000215457-19-006846-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434316/000031506619001046/0000315066-19-001046-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434316/000031506620000995/0000315066-20-000995-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434316/000083423720005406/0000834237-20-005406-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434316/000104018820000081/0001040188-20-000081-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000110465920056896/0001104659-20-056896-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000110465920056897/0001104659-20-056897-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000110465920074301/0001104659-20-074301-index.htm
2020-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1434316/000110465920074302/0001104659-20-074302-index.htm
2018-09-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1434316/000114420418051218/0001144204-18-051218-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000114420418051219/0001144204-18-051219-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000114420419023892/0001144204-19-023892-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000114420419023893/0001144204-19-023893-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000114420419037477/0001144204-19-037477-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000114420419044910/0001144204-19-044910-index.htm
2019-09-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1434316/000114420419044911/0001144204-19-044911-index.htm
2018-09-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434316/000119312518278765/0001193125-18-278765-index.htm
2018-09-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434316/000119312518280061/0001193125-18-280061-index.htm
2018-11-21S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1434316/000119312518332350/0001193125-18-332350-index.htm
2018-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000119312518332391/0001193125-18-332391-index.htm
2018-12-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1434316/000119312518356424/0001193125-18-356424-index.htm
2019-02-0810-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000119312519032261/0001193125-19-032261-index.htm
2019-03-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1434316/000119312519083478/0001193125-19-083478-index.htm
2019-04-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1434316/000119312519100680/0001193125-19-100680-index.htm
2019-09-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434316/000119312519242947/0001193125-19-242947-index.htm
2019-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434316/000119312519244195/0001193125-19-244195-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000119312519244198/0001193125-19-244198-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1434316/000119312520080623/0001193125-20-080623-index.htm
2020-03-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1434316/000119312520080634/0001193125-20-080634-index.htm
2020-06-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434316/000119312520163472/0001193125-20-163472-index.htm
2020-06-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434316/000119312520164911/0001193125-20-164911-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000119312520164916/0001193125-20-164916-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119003019/0001209191-19-003019-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119003022/0001209191-19-003022-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119003023/0001209191-19-003023-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119014022/0001209191-19-014022-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119016098/0001209191-19-016098-index.htm
2019-03-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119019968/0001209191-19-019968-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119019972/0001209191-19-019972-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119020986/0001209191-19-020986-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/0001209191-19-021717-index.htm
2019-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119027945/0001209191-19-027945-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119027946/0001209191-19-027946-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119027949/0001209191-19-027949-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119027950/0001209191-19-027950-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119027951/0001209191-19-027951-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119027952/0001209191-19-027952-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119032958/0001209191-19-032958-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/0001209191-19-039461-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119042382/0001209191-19-042382-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119042386/0001209191-19-042386-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119053272/0001209191-19-053272-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119053275/0001209191-19-053275-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119053277/0001209191-19-053277-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119053280/0001209191-19-053280-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/0001209191-20-003025-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120003026/0001209191-20-003026-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/0001209191-20-003027-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120003031/0001209191-20-003031-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120005968/0001209191-20-005968-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120006263/0001209191-20-006263-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120021788/0001209191-20-021788-index.htm
2020-05-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027055/0001209191-20-027055-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027063/0001209191-20-027063-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027069/0001209191-20-027069-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027078/0001209191-20-027078-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027086/0001209191-20-027086-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027090/0001209191-20-027090-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027100/0001209191-20-027100-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120027107/0001209191-20-027107-index.htm
2020-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120047476/0001209191-20-047476-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120047483/0001209191-20-047483-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120055368/0001209191-20-055368-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm
2020-04-21DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000143431620000001/0001434316-20-000001-index.htm
2020-07-06DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1434316/000143431620000002/0001434316-20-000002-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459018023467/0001564590-18-023467-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459018026210/0001564590-18-026210-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459018026214/0001564590-18-026214-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459018027760/0001564590-18-027760-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019000184/0001564590-19-000184-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019006257/0001564590-19-006257-index.htm
2019-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1434316/000156459019006258/0001564590-19-006258-index.htm
2019-03-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434316/000156459019006990/0001564590-19-006990-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019008253/0001564590-19-008253-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019016475/0001564590-19-016475-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019016519/0001564590-19-016519-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459019016536/0001564590-19-016536-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019025146/0001564590-19-025146-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019029319/0001564590-19-029319-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459019029333/0001564590-19-029333-index.htm
2019-08-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019030033/0001564590-19-030033-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019040354/0001564590-19-040354-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459019040360/0001564590-19-040360-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459019043510/0001564590-19-043510-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020000753/0001564590-20-000753-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020008139/0001564590-20-008139-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1434316/000156459020008141/0001564590-20-008141-index.htm
2020-03-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434316/000156459020008196/0001564590-20-008196-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020015011/0001564590-20-015011-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020019242/0001564590-20-019242-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020021242/0001564590-20-021242-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020024158/0001564590-20-024158-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459020024213/0001564590-20-024213-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020036776/0001564590-20-036776-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459020036806/0001564590-20-036806-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020040672/0001564590-20-040672-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434316/000156459020051284/0001564590-20-051284-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434316/000156459020051301/0001564590-20-051301-index.htm
2019-02-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1434316/999999999719000597/9999999997-19-000597-index.htm

Fate Therapeutics, Inc (FATE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fate Therapeutics, Inc (FATE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 179%
Institutional Ownership: 10089%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-11-05CINDY TAHLGeneral Counsel and SecretarySell16,682.0050.55843,253.41102,118.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm
2018-09-25Redmile Group, LLCDirectorBuy3,703,704.0013.5050,000,004.0010,359,666.00https://www.sec.gov/Archives/edgar/data/1434316/000114420418051219/0001144204-18-051219-index.htm
2020-01-08CINDY TAHLGeneral Counsel and SecretaryBuy25,000.00105,218.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003026/0001209191-20-003026-index.htm
2020-10-01CINDY TAHLGeneral Counsel and SecretarySell6,260.0041.09257,234.04106,501.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm
2020-11-05CINDY TAHLGeneral Counsel and SecretaryBuy9,282.002.7325,339.86108,800.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm
2019-08-01Amir NashatDirectorSell29,782.0022.53670,970.591,099,772.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-08-01Amir NashatDirectorSell299.0022.536,736.3211,034.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2020-09-14Bahram ValamehrChief Development OfficerSell600.0034.6520,791.98111,611.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2019-09-16Redmile Group, LLCDirectorBuy857,143.0017.5015,000,002.5011,216,809.00https://www.sec.gov/Archives/edgar/data/1434316/000114420419044910/0001144204-19-044910-index.htm
2020-09-14Bahram ValamehrChief Development OfficerBuy21,924.002.9063,579.60112,211.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2020-10-01CINDY TAHLGeneral Counsel and SecretarySell21,757.0040.26875,902.01112,761.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm
2019-07-31Amir NashatDirectorSell30,045.0022.53677,022.011,129,554.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-07-31Amir NashatDirectorSell302.0022.536,805.1811,333.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-02-25CINDY TAHLGeneral Counsel and SecretaryBuy25,000.002.9072,500.00115,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119014022/0001209191-19-014022-index.htm
2019-03-01CINDY TAHLGeneral Counsel and SecretaryBuy25,000.002.9072,500.00115,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119016098/0001209191-19-016098-index.htm
2019-07-30Amir NashatDirectorSell87,010.0022.511,958,325.371,159,599.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-30Amir NashatDirectorSell873.0022.5119,648.5211,635.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2020-09-14Daniel D ShoemakerChief Scientific OfficerSell5,713.0037.12212,073.99118,091.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm
2020-11-05CINDY TAHLGeneral Counsel and SecretaryBuy10,000.002.9029,000.00118,800.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm
2019-10-15Daniel D ShoemakerChief Scientific OfficerSell11,800.0014.29168,592.50123,791.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119053272/0001209191-19-053272-index.htm
2019-12-30Daniel D ShoemakerChief Scientific OfficerSell100.0020.342,034.00123,791.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm
2020-09-14Daniel D ShoemakerChief Scientific OfficerSell17,887.0036.11645,908.51123,804.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm
2019-12-30Daniel D ShoemakerChief Scientific OfficerSell24,900.0019.49485,393.13123,891.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm
2019-07-29Amir NashatDirectorSell317.0022.507,132.501,246,609.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-26Amir NashatDirectorSell26,852.0022.50604,170.001,246,926.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-29Amir NashatDirectorSell3.0022.5067.5012,508.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-26Amir NashatDirectorSell270.0022.506,075.0312,511.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2020-06-11Redmile Group, LLCDirectorBuy1,412,928.0028.3139,999,991.6812,629,737.00https://www.sec.gov/Archives/edgar/data/1434316/000110465920074301/0001104659-20-074301-index.htm
2019-07-24Amir NashatDirectorSell19,168.0022.51431,389.261,273,778.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2019-07-24Amir NashatDirectorSell192.0022.514,321.0912,781.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2020-10-16CINDY TAHLGeneral Counsel and SecretaryBuy29,199.002.7379,713.27128,717.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120055368/0001209191-20-055368-index.htm
2019-07-23Amir NashatDirectorSell59,854.0022.511,347,014.271,292,946.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2019-07-23Amir NashatDirectorSell601.0022.5113,525.5112,973.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2020-10-01CINDY TAHLGeneral Counsel and SecretaryBuy35,000.002.7395,550.00134,518.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm
2019-07-22Amir NashatDirectorSell46,992.0022.521,058,457.211,352,800.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-01-07Daniel D ShoemakerChief Scientific OfficerBuy45,000.00135,591.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003019/0001209191-19-003019-index.htm
2019-03-28Daniel D ShoemakerChief Scientific OfficerSell12,500.0016.94211,702.50135,591.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/0001209191-19-021717-index.htm
2019-06-27Daniel D ShoemakerChief Scientific OfficerSell12,500.0020.21252,610.00135,591.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/0001209191-19-039461-index.htm
2019-07-22Amir NashatDirectorSell472.0022.5210,631.3813,574.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-19Amir NashatDirectorSell1,016.0022.5022,860.001,399,792.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-18Amir NashatDirectorSell20,656.0022.50464,848.821,400,808.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-19Amir NashatDirectorSell10.0022.50225.0014,046.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-18Amir NashatDirectorSell208.0022.504,680.9214,056.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2020-09-14Daniel D ShoemakerChief Scientific OfficerSell1,400.0035.4049,557.06141,691.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm
2020-01-08Daniel D ShoemakerChief Scientific OfficerSell5,700.0020.70117,986.01143,091.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/0001209191-20-003025-index.htm
2019-01-30Amir NashatDirectorSell463.0014.166,558.161,473,186.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm
2019-01-30Amir NashatDirectorSell340.0014.164,815.931,473,649.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm
2019-01-30Amir NashatDirectorSell990.0014.1614,022.861,473,989.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm
2019-01-30Amir NashatDirectorSell51,224.0014.16725,562.351,474,979.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm
2019-03-28Daniel D ShoemakerChief Scientific OfficerBuy12,500.002.9036,250.00148,091.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/0001209191-19-021717-index.htm
2019-06-27Daniel D ShoemakerChief Scientific OfficerBuy12,500.002.9036,250.00148,091.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/0001209191-19-039461-index.htm
2019-12-30Daniel D ShoemakerChief Scientific OfficerBuy25,000.002.9072,500.00148,791.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm
2020-01-08Daniel D ShoemakerChief Scientific OfficerBuy25,000.00148,791.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/0001209191-20-003025-index.htm
2020-11-04CINDY TAHLGeneral Counsel and SecretaryBuy51,519.002.73140,646.87151,037.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm
2019-01-29Amir NashatDirectorSell941.0014.1613,326.441,526,203.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm
2019-01-29Amir NashatDirectorSell644.0014.169,120.331,527,144.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm
2019-01-29Amir NashatDirectorSell1,834.0014.1625,973.291,527,788.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm
2019-01-29Amir NashatDirectorSell94,081.0014.161,332,375.121,529,622.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm
2019-01-28Amir NashatDirectorSell675.0013.789,303.121,623,703.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm
2019-01-28Amir NashatDirectorSell463.0013.786,381.251,624,378.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm
2019-01-28Amir NashatDirectorSell1,316.0013.7818,137.641,624,841.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm
2019-01-28Amir NashatDirectorSell67,546.0013.78930,945.991,626,157.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm
2019-01-25Amir NashatDirectorSell868.0014.1412,275.001,693,703.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm
2019-01-25Amir NashatDirectorSell595.0014.148,414.311,694,571.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm
2019-01-25Amir NashatDirectorSell1,693.0014.1423,941.901,695,166.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm
2019-01-25Amir NashatDirectorSell86,844.0014.141,228,121.791,696,859.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm
2019-01-18Amir NashatDirectorSell381.0016.286,203.061,783,703.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm
2019-01-18Amir NashatDirectorSell261.0016.284,249.341,784,084.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm
2019-01-18Amir NashatDirectorSell743.0016.2812,097.011,784,345.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm
2019-01-18Amir NashatDirectorSell38,098.0016.28620,284.971,785,088.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm
2018-12-20Amir NashatDirectorSell323.0012.253,957.751,823,186.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm
2018-12-20Amir NashatDirectorSell221.0012.252,707.941,823,509.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm
2018-12-20Amir NashatDirectorSell630.0012.257,719.451,823,730.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm
2018-12-20Amir NashatDirectorSell32,300.0012.25395,775.131,824,360.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm
2018-12-19Amir NashatDirectorSell240.0013.963,351.101,856,660.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell640.0013.198,444.541,856,900.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell180.0013.962,513.301,857,540.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell423.0013.175,569.391,857,720.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell454.0013.966,337.431,858,143.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell1,261.0013.2016,650.621,858,597.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell23,023.0013.96321,364.241,859,858.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-19Amir NashatDirectorSell64,989.0013.21858,361.711,882,881.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm
2018-12-13Amir NashatDirectorSell172.0016.672,867.601,947,870.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm
2018-12-13Amir NashatDirectorSell118.0016.671,967.311,948,042.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm
2018-12-13Amir NashatDirectorSell334.0016.675,568.481,948,160.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm
2018-12-13Amir NashatDirectorSell17,164.0016.67286,159.921,948,494.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm
2018-12-12Amir NashatDirectorSell4,101.0016.7868,826.261,965,658.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm
2018-12-12Amir NashatDirectorSell2,809.0016.7847,142.891,969,759.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm
2018-12-12Amir NashatDirectorSell7,993.0016.78134,144.921,972,568.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm
2018-12-12Amir NashatDirectorSell410,097.0016.786,882,575.931,980,561.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm
2019-08-01Amir NashatDirectorSell581.0022.5313,089.5821,438.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-07-31Amir NashatDirectorSell586.0022.5313,204.6322,019.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-07-30Amir NashatDirectorSell1,696.0022.5138,171.7022,605.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2018-12-11Amir NashatDirectorSell796.0016.7113,302.512,390,658.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm
2018-12-11Amir NashatDirectorSell546.0016.719,124.592,391,454.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm
2018-12-11Amir NashatDirectorSell1,552.0016.7125,936.562,392,000.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm
2018-12-11Amir NashatDirectorSell79,634.0016.711,330,819.522,393,552.00https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm
2019-07-29Amir NashatDirectorSell6.0022.50135.0024,301.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-26Amir NashatDirectorSell523.0022.5011,767.5024,307.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-24Amir NashatDirectorSell374.0022.518,417.1324,830.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2019-07-23Amir NashatDirectorSell1,167.0022.5126,263.3425,204.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2019-07-22Amir NashatDirectorSell917.0022.5220,654.6926,371.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-19Amir NashatDirectorSell20.0022.50450.0027,288.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-18Amir NashatDirectorSell403.0022.509,069.1927,308.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2020-03-30WILLIAM H RASTETTERDirectorBuy28,461.001.3738,991.5728,461.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120021788/0001209191-20-021788-index.htm
2019-10-15J Scott WolchkoPresident and CEOSell21,017.0014.44303,458.16353,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119053280/0001209191-19-053280-index.htm
2019-12-19J Scott WolchkoPresident and CEOSell25,000.0020.08501,897.50353,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm
2019-12-20J Scott WolchkoPresident and CEOSell25,000.0020.17504,157.50353,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm
2019-01-07J Scott WolchkoPresident and CEOBuy250,000.00374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003023/0001209191-19-003023-index.htm
2019-03-21J Scott WolchkoPresident and CEOSell20,000.0017.61352,160.00374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119020986/0001209191-19-020986-index.htm
2019-04-17J Scott WolchkoPresident and CEOSell1,092.0016.1117,587.97374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-04-17J Scott WolchkoPresident and CEOSell7,449.0016.18120,544.19374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-04-18J Scott WolchkoPresident and CEOSell6,843.0016.01109,583.80374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-04-18J Scott WolchkoPresident and CEOSell4,616.0016.0273,925.24374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-05-16J Scott WolchkoPresident and CEOSell12,037.0019.54235,253.54374,881.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm
2019-04-17J Scott WolchkoPresident and CEOBuy1,092.001.631,779.96375,973.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-12-19J Scott WolchkoPresident and CEOBuy25,000.002.7067,500.00378,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm
2019-12-20J Scott WolchkoPresident and CEOBuy25,000.002.7067,500.00378,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm
2019-04-18J Scott WolchkoPresident and CEOBuy4,616.001.637,524.08379,497.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-04-18J Scott WolchkoPresident and CEOBuy6,843.001.6311,154.09381,724.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-04-17J Scott WolchkoPresident and CEOBuy7,449.001.6312,141.87382,330.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm
2019-05-16J Scott WolchkoPresident and CEOSell2,298.0018.4642,430.27386,918.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm
2019-05-16J Scott WolchkoPresident and CEOBuy14,335.001.6323,366.05389,216.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm
2019-03-21J Scott WolchkoPresident and CEOBuy20,000.001.6332,600.00394,881.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119020986/0001209191-19-020986-index.htm
2020-08-17Edward J III DulacChief Financial OfficerBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120047483/0001209191-20-047483-index.htm
2020-01-08J Scott WolchkoPresident and CEOBuy66,000.00419,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003031/0001209191-20-003031-index.htm
2020-01-30J Scott WolchkoPresident and CEOSell25,000.0025.45636,302.50419,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120005968/0001209191-20-005968-index.htm
2020-01-30J Scott WolchkoPresident and CEOBuy25,000.002.7067,500.00444,969.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120005968/0001209191-20-005968-index.htm
2019-01-07CINDY TAHLGeneral Counsel and SecretarySell25,000.0016.00400,000.0045,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-01-07CINDY TAHLGeneral Counsel and SecretaryBuy2,008.001.372,750.9647,426.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-01-07CINDY TAHLGeneral Counsel and SecretaryBuy2,080.001.693,515.2049,506.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-01-07CINDY TAHLGeneral Counsel and SecretaryBuy8,461.001.6914,299.0957,967.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-10-15Bahram ValamehrChief Development OfficerSell6,200.0014.1887,890.5866,758.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119053277/0001209191-19-053277-index.htm
2019-01-07CINDY TAHLGeneral Counsel and SecretaryBuy12,451.002.9036,107.9070,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-01-07Bahram ValamehrChief Development OfficerBuy45,000.0072,958.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003022/0001209191-19-003022-index.htm
2019-08-01Amir NashatDirectorSell204.0022.534,596.007,539.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-07-31Amir NashatDirectorSell206.0022.534,641.987,743.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm
2019-07-30Amir NashatDirectorSell596.0022.5113,414.117,949.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-10-15CINDY TAHLGeneral Counsel and SecretarySell10,200.0014.24145,291.8680,218.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119053275/0001209191-19-053275-index.htm
2019-07-29Amir NashatDirectorSell3.0022.5067.508,545.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2019-07-26Amir NashatDirectorSell184.0022.504,140.008,548.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm
2020-01-08Bahram ValamehrChief Development OfficerSell5,700.0020.69117,947.2586,058.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/0001209191-20-003027-index.htm
2020-02-03Bahram ValamehrChief Development OfficerBuy1,153.001.691,948.5787,211.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120006263/0001209191-20-006263-index.htm
2020-09-14Bahram ValamehrChief Development OfficerSell600.0037.4922,494.0087,211.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2019-07-24Amir NashatDirectorSell132.0022.512,970.778,732.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2020-09-14Bahram ValamehrChief Development OfficerSell7,016.0036.93259,084.7487,811.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2019-07-23Amir NashatDirectorSell411.0022.519,249.608,864.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm
2020-09-14Bahram ValamehrChief Development OfficerBuy3,076.001.695,198.4490,287.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2019-01-07CINDY TAHLGeneral Counsel and SecretaryBuy45,000.0090,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm
2019-02-25CINDY TAHLGeneral Counsel and SecretarySell25,000.0016.07401,820.0090,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119014022/0001209191-19-014022-index.htm
2019-03-01CINDY TAHLGeneral Counsel and SecretarySell25,000.0016.15403,697.5090,418.00https://www.sec.gov/Archives/edgar/data/1434316/000120919119016098/0001209191-19-016098-index.htm
2020-01-08Bahram ValamehrChief Development OfficerBuy25,000.0091,758.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/0001209191-20-003027-index.htm
2019-07-22Amir NashatDirectorSell323.0022.527,275.359,275.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2020-09-14Bahram ValamehrChief Development OfficerSell16,784.0036.03604,653.6794,827.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm
2019-07-19Amir NashatDirectorSell7.0022.50157.509,598.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2019-07-18Amir NashatDirectorSell142.0022.503,195.619,605.00https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm
2020-01-08CINDY TAHLGeneral Counsel and SecretarySell5,700.0020.72118,085.1999,518.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120003026/0001209191-20-003026-index.htm
2020-10-01CINDY TAHLGeneral Counsel and SecretarySell6,983.0041.95292,929.1799,518.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm
2020-10-16CINDY TAHLGeneral Counsel and SecretarySell29,199.0050.251,467,211.7999,518.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120055368/0001209191-20-055368-index.htm
2020-11-04CINDY TAHLGeneral Counsel and SecretarySell51,519.0050.412,597,139.7699,518.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm
2020-11-05CINDY TAHLGeneral Counsel and SecretarySell2,600.0051.15132,998.5899,518.00https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm